Impact of HIV, oral microbiome and mycobiome on oral HPV persistence

HIV、口腔微生物组和真菌组对口腔 HPV 持久性的影响

基本信息

  • 批准号:
    10683323
  • 负责人:
  • 金额:
    $ 82.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-01 至 2027-08-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT Oral human papillomavirus (HPV) infections and HPV-associated papillomas and cancers continue to rise, especially in people living with HIV (PLWH). Specifically, rates of HPV-associated oral and oropharyngeal cancer are increasing at an alarming rate. Using large population-based longitudinal studies, our work indicated an increased risk of oral lesions and head and neck cancers with not only HPV16, but unexpectedly cutaneous beta and gamma HPVs as well. Studying risk factors, we identified an interaction between smoking and HIV serostatus with increased prevalence of oral high-risk alpha and beta-HPV detection. In addition to oral HPV, HIV affects the composition of the oral microbiome, which has also been associated with increased susceptibility to oral HPV infection, persistence, and progression to HPV-driven cancer. Taken together, these findings indicate a continuing public health concern of HPV-related oral diseases for PLWH. The proposed study will leverage repeat oral saliva samples collected from N=2046 male and female PLWH, and N=1334 HIV[-] individuals enrolled in the MACS-WIHS Combined Cohort Study (MWCSS). Specifically, we will investigate the associations between the oral microbiome and mycobiome and risk of acquisition and persistence of high-risk alpha, beta, and gamma oral HPV. The scientific premise of the study is that alterations in the oral microbiome / mycobiome resulting from HIV and smoking influence oral HPV natural history. We will use novel sequencing methods developed by our team, including next generation sequencing and metagenomics, to profile the HPV virome (alpha, beta, and gamma HPV), oral bacterial (16S rRNA) and fungal communities (using a recently developed ITS1 assay with increased sensitivity for Candida developed in the Burk lab), functional gene capacity (determined from shotgun metagenomic sequencing), and cytokine profiles (derived from oral saliva protein analyses). Differences in the oral microbiome / mycobiome between PLWH and HIV[-] individuals will be assessed, as well as markers of HIV disease and smoking, with respect to oral HPV persistence. Taking advantage of serial samples collected in MWCCS participants, we will characterize oral microbiome / mycobiome changes over time in response to CD4 count and HIV RNA level, smoking, and the oral microbiome / mycobiome to address the following specific aims: 1) Determine the combined effects of HIV and smoking on risk of oral HPV persistence; 2) Study the associations between the oral microbiome / mycobiome and risk of oral HPV persistence; 3) Characterize the microbial function and oral inflammation/immune pathways associated with risk of oral HPV persistence. We hypothesize that the oral microbiome and mycobiome influenced by HIV and smoking exhibit significantly higher proportions of virulence factors, which in turn dysregulate the oral barrier immunity and integrity, facilitating persistence of oral high-risk HPV types associated with increased risks for oral and oropharyngeal cancer.
摘要 口腔人乳头瘤病毒(HPV)感染和HPV相关的乳头状瘤和癌症继续上升, 尤其是艾滋病毒携带者(PLWH)。具体地说,口腔和口咽部HPV相关的比率 癌症正在以惊人的速度增长。利用大规模的基于人口的纵向研究,我们的工作 表明口腔病变和头颈癌的风险增加,不仅感染了HPV16,而且出乎意料地 皮肤上的贝塔病毒和伽马病毒也一样。通过对风险因素的研究,我们发现吸烟与吸烟之间存在相互作用 以及艾滋病毒血清状态,并增加口服高危甲型和乙型HPV检测的流行率。除了……之外 口腔HPV,HIV影响口腔微生物组的组成,这也与增加 对口腔HPV感染的易感性、持久性和进展为HPV驱动的癌症。这些加在一起, 研究结果表明,PLWH的HPV相关口腔疾病仍是一个公共卫生问题。建议数 研究将利用从N=2046名男性和女性PLWH和N=1334名男性和女性收集的重复口腔唾液样本 艾滋病毒[-]参加MACS-WIHS联合队列研究(MWCS)的个人。具体来说,我们将 调查口腔微生物组和真菌组与获得和感染风险之间的关系 高危甲型、乙型和伽玛型口服HPV持续存在。这项研究的科学前提是 HIV和吸烟引起的口腔微生物组/真菌组的变化影响口腔HPV自然界 历史。我们将使用我们团队开发的新的测序方法,包括下一代测序 和元基因组学,以描述HPV病毒体(阿尔法、贝塔和伽马HPV)、口腔细菌(16S RRNA)和 真菌群落(使用最近开发的ITS1检测方法,提高了对念珠菌的敏感性 Burk实验室)、功能基因容量(通过鸟枪式元基因组测序确定)和细胞因子 个人资料(来自口腔唾液蛋白分析)。口腔微生物组/真菌组的差异 将评估PLWH和艾滋病毒[-]个人,以及艾滋病毒疾病和吸烟的标志物。 口腔人乳头瘤病毒持续存在。利用在MWCCS参与者中收集的系列样本,我们将 表征口腔微生物组/真菌生物组随时间的变化,以响应CD4计数和HIV RNA水平, 吸烟,和口腔微生物组/真菌组解决以下具体目标:1)确定 HIV和吸烟对口腔HPV持续感染风险的联合影响;2)研究 口腔微生物群/真菌菌群与口腔HPV持续感染的风险;3)表征口腔微生物功能和口腔 炎症/免疫途径与口服HPV持续存在的风险相关。我们假设口服液 受艾滋病毒和吸烟影响的微生物组和真菌组显示出明显更高的毒力比例 这些因素反过来又扰乱了口腔屏障免疫和完整性,促进了口腔高危人群的持续 HPV类型与口腔和口咽癌风险增加相关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert D Burk其他文献

1296 FETAL ORIGIN OF MATERNAL SERUM ALPHA-FETOPROTEIN (AFP) DEMONSTRATED BY DNA-RNA HYBRIDIZATION
通过 DNA-RNA 杂交技术证明母体血清甲胎蛋白(AFP)的胎儿起源
  • DOI:
    10.1203/00006450-198504000-01320
  • 发表时间:
    1985-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    R Gordon Huteheon;Harold M Nltowsky;Sachiko Nakagawa;Robert D Burk
  • 通讯作者:
    Robert D Burk
Oral HPV associated with differences in oral microbiota beta diversity and microbiota abundance.
口腔 HPV 与口腔微生物群 β 多样性和微生物群丰度的差异相关。
  • DOI:
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
    Yuehan Zhang;G. D’Souza;Carole Fakhry;Elaine O Bigelow;Mykhaylo Usyk;Robert D Burk;Ni Zhao
  • 通讯作者:
    Ni Zhao
Association of meal timing with adiposity measures and gut microbiome characteristics in a cohort study: the Hispanic Community Health Study/Study of Latinos
一项队列研究中进餐时间与肥胖测量指标和肠道微生物组特征的关联:西班牙裔社区健康研究/拉丁裔研究
  • DOI:
    10.1016/j.ajcnut.2025.04.003
  • 发表时间:
    2025-06-01
  • 期刊:
  • 影响因子:
    6.900
  • 作者:
    Sarah K Alver;Brandilyn A Peters;Yasmin Mossavar-Rahmani;Qibin Qi;Amanda C McClain;Linda Van Horn;Robert D Burk;Robert C Kaplan
  • 通讯作者:
    Robert C Kaplan

Robert D Burk的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert D Burk', 18)}}的其他基金

Multi-omic signatures of gut dysbiosis and cardiovascular comorbidities associated with HIV infection
与 HIV 感染相关的肠道菌群失调和心血管合并症的多组学特征
  • 批准号:
    10762411
  • 财政年份:
    2023
  • 资助金额:
    $ 82.06万
  • 项目类别:
Epidemiology of diet, metabolism and non-alcoholic fatty liver disease in Hispanic/Latino adults
西班牙裔/拉丁裔成人饮食、代谢和非酒精性脂肪肝的流行病学
  • 批准号:
    10735454
  • 财政年份:
    2023
  • 资助金额:
    $ 82.06万
  • 项目类别:
Impact of HIV, oral microbiome and mycobiome on oral HPV persistence
HIV、口腔微生物组和真菌组对口腔 HPV 持久性的影响
  • 批准号:
    10534011
  • 财政年份:
    2022
  • 资助金额:
    $ 82.06万
  • 项目类别:
Investigations Into The Molecular Pathogenesis Of Cervical Glandular Neoplasias
宫颈腺瘤的分子发病机制研究
  • 批准号:
    10208823
  • 财政年份:
    2020
  • 资助金额:
    $ 82.06万
  • 项目类别:
Investigations Into The Molecular Pathogenesis Of Cervical Glandular Neoplasias
宫颈腺瘤的分子发病机制研究
  • 批准号:
    10652422
  • 财政年份:
    2020
  • 资助金额:
    $ 82.06万
  • 项目类别:
Investigations Into The Molecular Pathogenesis Of Cervical Glandular Neoplasias
宫颈腺瘤的分子发病机制研究
  • 批准号:
    9897227
  • 财政年份:
    2020
  • 资助金额:
    $ 82.06万
  • 项目类别:
Investigations Into The Molecular Pathogenesis Of Cervical Glandular Neoplasias
宫颈腺瘤的分子发病机制研究
  • 批准号:
    10443811
  • 财政年份:
    2020
  • 资助金额:
    $ 82.06万
  • 项目类别:
Next Generation of HPV and Cervical Cancer Research in HIV+ Women
HIV 女性中的下一代 HPV 和宫颈癌研究
  • 批准号:
    10203871
  • 财政年份:
    2018
  • 资助金额:
    $ 82.06万
  • 项目类别:
Next Generation of HPV and Cervical Cancer Research in HIV+ Women
HIV 女性中的下一代 HPV 和宫颈癌研究
  • 批准号:
    10440387
  • 财政年份:
    2018
  • 资助金额:
    $ 82.06万
  • 项目类别:
Epidemiology of the gut microbiome, prediabetes and diabetes in Latinos
拉丁裔肠道微生物组、糖尿病前期和糖尿病的流行病学
  • 批准号:
    9194787
  • 财政年份:
    2016
  • 资助金额:
    $ 82.06万
  • 项目类别:

相似海外基金

Development of anti-scirrhous stomach cancer produced by the deep-sea actinomyces
深海放线菌抗硬胃癌的开发
  • 批准号:
    21H03007
  • 财政年份:
    2021
  • 资助金额:
    $ 82.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Comprehensive analysis of the fluoride-effects on the metabolic mechanism of oral Actinomyces
氟对口腔放线菌代谢机制影响的综合分析
  • 批准号:
    16K20447
  • 财政年份:
    2016
  • 资助金额:
    $ 82.06万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Breakthrough of fluoride-functional mechanism and establishment of its utilization for oral Actinomyces
氟作用机制的突破及其在口腔放线菌中的应用
  • 批准号:
    25861783
  • 财政年份:
    2013
  • 资助金额:
    $ 82.06万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The role of the initial colonizer Actinomyces oris in dental plaque formation.
初始定殖者口放线菌在牙菌斑形成中的作用。
  • 批准号:
    24592790
  • 财政年份:
    2012
  • 资助金额:
    $ 82.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome sequencing and mutational analysis of the Actinomyces strains with enhanced biofilm phenotype
具有增强生物膜表型的放线菌菌株的基因组测序和突变分析
  • 批准号:
    23792118
  • 财政年份:
    2011
  • 资助金额:
    $ 82.06万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Molecular Assembly on the Cell Surface of Actinomyces
放线菌细胞表面的分子组装
  • 批准号:
    8774895
  • 财政年份:
    2008
  • 资助金额:
    $ 82.06万
  • 项目类别:
Molecular Assembly on the Cell Surface of Actinomyces
放线菌细胞表面的分子组装
  • 批准号:
    10455056
  • 财政年份:
    2008
  • 资助金额:
    $ 82.06万
  • 项目类别:
Molecular Assembly on the Cell Surface of Actinomyces
放线菌细胞表面的分子组装
  • 批准号:
    8588304
  • 财政年份:
    2008
  • 资助金额:
    $ 82.06万
  • 项目类别:
Molecular Assembly on the Cell Surface of Actinomyces
放线菌细胞表面的分子组装
  • 批准号:
    7783826
  • 财政年份:
    2008
  • 资助金额:
    $ 82.06万
  • 项目类别:
Molecular Assembly on the Cell Surface of Actinomyces
放线菌细胞表面的分子组装
  • 批准号:
    8911399
  • 财政年份:
    2008
  • 资助金额:
    $ 82.06万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了